Multimorbidity and COVID-19 in Canada: How the Pandemic Has Highlighted a Key and Yet Underappreciated Risk Factor

doi:10.5770/cgj.25.611

. 2022 Dec 1;25(4):404-406.

doi: 10.5770/cgj.25.611. eCollection 2022 Dec.

Multimorbidity and COVID-19 in Canada: How the Pandemic Has Highlighted a Key and Yet Underappreciated Risk Factor

Matthew B Downer¹, Samir K Sinha^{1

2}

Affiliations

¹ National Institute on Ageing, Toronto Metropolitan University, Toronto, ON.
² Department of Geriatrics, Sinai Health System and University Health Network, Toronto, ON.

PMID: 36505917
PMCID: PMC9684020
DOI: 10.5770/cgj.25.611

Multimorbidity and COVID-19 in Canada: How the Pandemic Has Highlighted a Key and Yet Underappreciated Risk Factor

Matthew B Downer et al. Can Geriatr J. 2022.

. 2022 Dec 1;25(4):404-406.

doi: 10.5770/cgj.25.611. eCollection 2022 Dec.

Authors

Matthew B Downer¹, Samir K Sinha^{1

2}

Affiliations

¹ National Institute on Ageing, Toronto Metropolitan University, Toronto, ON.
² Department of Geriatrics, Sinai Health System and University Health Network, Toronto, ON.

PMID: 36505917
PMCID: PMC9684020
DOI: 10.5770/cgj.25.611

No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES We have read and understood the Canadian Geriatrics Journal’s policy on conflicts of interest disclosure and declare the following interests: MD reports research funding from the Rhodes Trust and CIHR (DFD-175796). SS reports memberships on advisory boards (TELUS Heath Medical Advisory Board, Dairy Farmers of Ontario, Bayshore Health, Closing the Gap Health Care) and research funding from CIHR, PHAC, and the New Horizons for Seniors Program.

References

1. Steffler M, Li Y, Weir S, et al. Trends in prevalence of chronic disease and multimorbidity in Ontario, Canada. CMAJ. 2021;193(8):E270–E27. doi: 10.1503/cmaj.201473. - DOI - PMC - PubMed
1. Nunes BP, Flores TR, Mielke GI, Thumé E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130–38. doi: 10.1016/j.archger.2016.07.008. - DOI - PubMed
1. Calderón-Larrañaga A, Vetrano DL, Ferrucci L, et al. Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways. J Intern Med. 2019;285(3):255–71. doi: 10.1111/joim.12843. - DOI - PMC - PubMed
1. Fortin M, Bravo G, Hudon C, et al. Relationship Between Multimorbidity and Health-Related Quality of Life of Patients in Primary Care. Qual Life Res. 2006;15(1):83–91. doi: 10.1007/s11136-005-8661-z. - DOI - PubMed
1. McQueenie R, Foster HM, Jani BD, et al. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2020;15(8):e0238091. doi: 10.1371/journal.pone.0238091. - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

[1] Steffler M, Li Y, Weir S, et al. Trends in prevalence of chronic disease and multimorbidity in Ontario, Canada. CMAJ. 2021;193(8):E270–E27. doi: 10.1503/cmaj.201473. - DOI - PMC - PubMed

[2] Steffler M, Li Y, Weir S, et al. Trends in prevalence of chronic disease and multimorbidity in Ontario, Canada. CMAJ. 2021;193(8):E270–E27. doi: 10.1503/cmaj.201473. - DOI - PMC - PubMed

[3] Nunes BP, Flores TR, Mielke GI, Thumé E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130–38. doi: 10.1016/j.archger.2016.07.008. - DOI - PubMed

[4] Nunes BP, Flores TR, Mielke GI, Thumé E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130–38. doi: 10.1016/j.archger.2016.07.008. - DOI - PubMed

[5] Calderón-Larrañaga A, Vetrano DL, Ferrucci L, et al. Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways. J Intern Med. 2019;285(3):255–71. doi: 10.1111/joim.12843. - DOI - PMC - PubMed

[6] Calderón-Larrañaga A, Vetrano DL, Ferrucci L, et al. Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways. J Intern Med. 2019;285(3):255–71. doi: 10.1111/joim.12843. - DOI - PMC - PubMed

[7] Fortin M, Bravo G, Hudon C, et al. Relationship Between Multimorbidity and Health-Related Quality of Life of Patients in Primary Care. Qual Life Res. 2006;15(1):83–91. doi: 10.1007/s11136-005-8661-z. - DOI - PubMed

[8] Fortin M, Bravo G, Hudon C, et al. Relationship Between Multimorbidity and Health-Related Quality of Life of Patients in Primary Care. Qual Life Res. 2006;15(1):83–91. doi: 10.1007/s11136-005-8661-z. - DOI - PubMed

[9] McQueenie R, Foster HM, Jani BD, et al. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2020;15(8):e0238091. doi: 10.1371/journal.pone.0238091. - DOI - PMC - PubMed

[10] McQueenie R, Foster HM, Jani BD, et al. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2020;15(8):e0238091. doi: 10.1371/journal.pone.0238091. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Multimorbidity and COVID-19 in Canada: How the Pandemic Has Highlighted a Key and Yet Underappreciated Risk Factor

Affiliations

Multimorbidity and COVID-19 in Canada: How the Pandemic Has Highlighted a Key and Yet Underappreciated Risk Factor

Authors

Affiliations

Conflict of interest statement

Similar articles

References

LinkOut - more resources

Full Text Sources